The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.
Identifieur interne : 001447 ( PubMed/Checkpoint ); précédent : 001446; suivant : 001448The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.
Auteurs : Carlos Franco-Paredes [Mexique] ; Peter Carrasco ; Jose Ignacio Santos PreciadoSource :
- Journal of immune based therapies and vaccines [ 1476-8518 ] ; 2009.
Abstract
Influenza viruses pose a permanent threat to human populations due to their ability to constantly adapt to impact immunologically susceptible individuals in the forms of epidemic and pandemics through antigenic drifts and antigenic shifts, respectively. Pandemic influenza preparedness is a critical step in responding to future influenza outbreaks. In this regard, responding to the current pandemic and preparing for future ones requires critical planning for the early phases where there is no availability of pandemic vaccine with rapid deployment of medical supplies for personal protection, antivirals, antibiotics and social distancing measures. In addition, it has become clear that responding to the current pandemic or preparing for future ones, nation states need to develop or strengthen their laboratory capability for influenza diagnosis as well as begin preparing their vaccine/antiviral deployment plans. Vaccine deployment plans are the critical missing link in pandemic preparedness and response. Rapid containment efforts are not effective and instead mitigation efforts should lead pandemic control efforts. We suggest that development of vaccine/antiviral deployment plans is a key preparedness step that allows nations identify logistic gaps in their response capacity.
DOI: 10.1186/1476-8518-7-2
PubMed: 19664217
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19664217Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.</title><author><name sortKey="Franco Paredes, Carlos" sort="Franco Paredes, Carlos" uniqKey="Franco Paredes C" first="Carlos" last="Franco-Paredes">Carlos Franco-Paredes</name><affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases and Clinical Immunology Unit, Department of Experimental Medicine, School of Medicine, Universidad Nacional Autónoma de México, Dr, Balmis 148, Col, Doctores, México. jisantosp@gmail.com.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Mexique</country><wicri:regionArea>Infectious Diseases and Clinical Immunology Unit, Department of Experimental Medicine, School of Medicine, Universidad Nacional Autónoma de México, Dr, Balmis 148, Col, Doctores</wicri:regionArea><wicri:noRegion>Doctores</wicri:noRegion></affiliation></author><author><name sortKey="Carrasco, Peter" sort="Carrasco, Peter" uniqKey="Carrasco P" first="Peter" last="Carrasco">Peter Carrasco</name></author><author><name sortKey="Preciado, Jose Ignacio Santos" sort="Preciado, Jose Ignacio Santos" uniqKey="Preciado J" first="Jose Ignacio Santos" last="Preciado">Jose Ignacio Santos Preciado</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19664217</idno><idno type="pmid">19664217</idno><idno type="doi">10.1186/1476-8518-7-2</idno><idno type="wicri:Area/PubMed/Corpus">001682</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001682</idno><idno type="wicri:Area/PubMed/Curation">001682</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001682</idno><idno type="wicri:Area/PubMed/Checkpoint">001447</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001447</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.</title><author><name sortKey="Franco Paredes, Carlos" sort="Franco Paredes, Carlos" uniqKey="Franco Paredes C" first="Carlos" last="Franco-Paredes">Carlos Franco-Paredes</name><affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases and Clinical Immunology Unit, Department of Experimental Medicine, School of Medicine, Universidad Nacional Autónoma de México, Dr, Balmis 148, Col, Doctores, México. jisantosp@gmail.com.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Mexique</country><wicri:regionArea>Infectious Diseases and Clinical Immunology Unit, Department of Experimental Medicine, School of Medicine, Universidad Nacional Autónoma de México, Dr, Balmis 148, Col, Doctores</wicri:regionArea><wicri:noRegion>Doctores</wicri:noRegion></affiliation></author><author><name sortKey="Carrasco, Peter" sort="Carrasco, Peter" uniqKey="Carrasco P" first="Peter" last="Carrasco">Peter Carrasco</name></author><author><name sortKey="Preciado, Jose Ignacio Santos" sort="Preciado, Jose Ignacio Santos" uniqKey="Preciado J" first="Jose Ignacio Santos" last="Preciado">Jose Ignacio Santos Preciado</name></author></analytic><series><title level="j">Journal of immune based therapies and vaccines</title><idno type="eISSN">1476-8518</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"> Influenza viruses pose a permanent threat to human populations due to their ability to constantly adapt to impact immunologically susceptible individuals in the forms of epidemic and pandemics through antigenic drifts and antigenic shifts, respectively. Pandemic influenza preparedness is a critical step in responding to future influenza outbreaks. In this regard, responding to the current pandemic and preparing for future ones requires critical planning for the early phases where there is no availability of pandemic vaccine with rapid deployment of medical supplies for personal protection, antivirals, antibiotics and social distancing measures. In addition, it has become clear that responding to the current pandemic or preparing for future ones, nation states need to develop or strengthen their laboratory capability for influenza diagnosis as well as begin preparing their vaccine/antiviral deployment plans. Vaccine deployment plans are the critical missing link in pandemic preparedness and response. Rapid containment efforts are not effective and instead mitigation efforts should lead pandemic control efforts. We suggest that development of vaccine/antiviral deployment plans is a key preparedness step that allows nations identify logistic gaps in their response capacity.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19664217</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1476-8518</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2009</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of immune based therapies and vaccines</Title><ISOAbbreviation>J Immune Based Ther Vaccines</ISOAbbreviation></Journal><ArticleTitle>The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1476-8518-7-2</ELocationID><Abstract><AbstractText> Influenza viruses pose a permanent threat to human populations due to their ability to constantly adapt to impact immunologically susceptible individuals in the forms of epidemic and pandemics through antigenic drifts and antigenic shifts, respectively. Pandemic influenza preparedness is a critical step in responding to future influenza outbreaks. In this regard, responding to the current pandemic and preparing for future ones requires critical planning for the early phases where there is no availability of pandemic vaccine with rapid deployment of medical supplies for personal protection, antivirals, antibiotics and social distancing measures. In addition, it has become clear that responding to the current pandemic or preparing for future ones, nation states need to develop or strengthen their laboratory capability for influenza diagnosis as well as begin preparing their vaccine/antiviral deployment plans. Vaccine deployment plans are the critical missing link in pandemic preparedness and response. Rapid containment efforts are not effective and instead mitigation efforts should lead pandemic control efforts. We suggest that development of vaccine/antiviral deployment plans is a key preparedness step that allows nations identify logistic gaps in their response capacity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franco-Paredes</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases and Clinical Immunology Unit, Department of Experimental Medicine, School of Medicine, Universidad Nacional Autónoma de México, Dr, Balmis 148, Col, Doctores, México. jisantosp@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrasco</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Preciado</LastName><ForeName>Jose Ignacio Santos</ForeName><Initials>JI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Immune Based Ther Vaccines</MedlineTA><NlmUniqueID>101152206</NlmUniqueID><ISSNLinking>1476-8518</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>07</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19664217</ArticleId><ArticleId IdType="pii">1476-8518-7-2</ArticleId><ArticleId IdType="doi">10.1186/1476-8518-7-2</ArticleId><ArticleId IdType="pmc">PMC2731762</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2007 Aug 8;298(6):644-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17684187</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Mar;15(3):365-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19239746</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 May 21;338:b2065</Citation><ArticleIdList><ArticleId IdType="pubmed">19460800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Jul 7;151(1):59-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19470591</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jun 19;324(5934):1557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19433588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2009 Jun;9(6):331</Citation><ArticleIdList><ArticleId IdType="pubmed">19467469</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19478718</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Sep 29;24(40-41):6367-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17240560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2006 Jul 18;145(2):138-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16801626</ArticleId></ArticleIdList></Reference><Reference><Citation>Salud Publica Mex. 2009 May-Jun;51(3):183-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19967302</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 Jun 19;58(23):641-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19543199</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol Suppl. 2005;(19):101-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16355870</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 May 8;324(5928):705</Citation><ArticleIdList><ArticleId IdType="pubmed">19423784</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2006 Nov 1;194 Suppl 2:S70-2</Citation><ArticleIdList><ArticleId IdType="pubmed">17163391</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2007 Oct 19;3(10):1470-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17953482</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Mexique</li></country></list><tree><noCountry><name sortKey="Carrasco, Peter" sort="Carrasco, Peter" uniqKey="Carrasco P" first="Peter" last="Carrasco">Peter Carrasco</name><name sortKey="Preciado, Jose Ignacio Santos" sort="Preciado, Jose Ignacio Santos" uniqKey="Preciado J" first="Jose Ignacio Santos" last="Preciado">Jose Ignacio Santos Preciado</name></noCountry><country name="Mexique"><noRegion><name sortKey="Franco Paredes, Carlos" sort="Franco Paredes, Carlos" uniqKey="Franco Paredes C" first="Carlos" last="Franco-Paredes">Carlos Franco-Paredes</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001447 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001447 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19664217
|texte= The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19664217" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |